Home > Research > Publications & Outputs > A practical approach for scaling up the alterna...

Links

Text available via DOI:

View graph of relations

A practical approach for scaling up the alternative strategy for the elimination of lymphatic filariasis in endemic countries - developing an action plan

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

A practical approach for scaling up the alternative strategy for the elimination of lymphatic filariasis in endemic countries - developing an action plan. / Kelly-Hope, Louise A; Stanton, Michelle C; Zouré, Honorat G M et al.
In: Global health research and policy, Vol. 2, 12, 01.05.2017.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Kelly-Hope, LA, Stanton, MC, Zouré, HGM, Kinvi, BE, Mikhailov, A, Tekle, A & King, JD 2017, 'A practical approach for scaling up the alternative strategy for the elimination of lymphatic filariasis in endemic countries - developing an action plan', Global health research and policy, vol. 2, 12. https://doi.org/10.1186/s41256-017-0032-0

APA

Kelly-Hope, L. A., Stanton, M. C., Zouré, H. G. M., Kinvi, B. E., Mikhailov, A., Tekle, A., & King, J. D. (2017). A practical approach for scaling up the alternative strategy for the elimination of lymphatic filariasis in endemic countries - developing an action plan. Global health research and policy, 2, Article 12. https://doi.org/10.1186/s41256-017-0032-0

Vancouver

Kelly-Hope LA, Stanton MC, Zouré HGM, Kinvi BE, Mikhailov A, Tekle A et al. A practical approach for scaling up the alternative strategy for the elimination of lymphatic filariasis in endemic countries - developing an action plan. Global health research and policy. 2017 May 1;2:12. doi: 10.1186/s41256-017-0032-0

Author

Kelly-Hope, Louise A ; Stanton, Michelle C ; Zouré, Honorat G M et al. / A practical approach for scaling up the alternative strategy for the elimination of lymphatic filariasis in endemic countries - developing an action plan. In: Global health research and policy. 2017 ; Vol. 2.

Bibtex

@article{f5bca1fbfe444d7a8e2680c3d52c4143,
title = "A practical approach for scaling up the alternative strategy for the elimination of lymphatic filariasis in endemic countries - developing an action plan",
abstract = "Background: Lymphatic filariasis (LF) is a vector-borne parasitic disease that is being targeted for elimination through mass drug administration (MDA). The co-distribution of Loa loa in Central Africa poses a significant barrier to the expansion of the MDA due to risk of severe adverse events (SAEs) associated with the drug ivermectin that is routinely used. National LF programmes are yet to significantly scale up in co-endemic areas and need a practical approach to make preliminary decisions based on the mapping status and potential treatment strategies.Methods: We reviewed relevant data available to WHO and in the literature for LF-L. loa endemic countries to develop a simple method to support the scale-up of MDA to eliminate LF.Results: A basic model for national LF programmes to work from at the administrative or implementation unit (IU) level has been developed for LF - L. loa co-endemic countries. The model includes five practical steps, which comprise the development of a national filarial database and a simple classification system to help determine the mapping status and most appropriate treatment strategy. Steps are colour-coded and linked to a general decision tree, which is also presented.Conclusions: This IU-level model is simple to follow and will help LF elimination programmes develop an action plan and scale up the implementation of alternative treatment strategies in L. loa co-endemic areas. The model could be further developed to incorporate the additional complexity of IUs where an intervention is required to eliminate onchocerciasis, particularly in hypo-endemic areas where ivermectin has not been used.",
author = "Kelly-Hope, {Louise A} and Stanton, {Michelle C} and Zour{\'e}, {Honorat G M} and Kinvi, {Boniface E} and Alexei Mikhailov and Afework Tekle and King, {Jonathan D}",
year = "2017",
month = may,
day = "1",
doi = "10.1186/s41256-017-0032-0",
language = "English",
volume = "2",
journal = "Global health research and policy",
issn = "2397-0642",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - A practical approach for scaling up the alternative strategy for the elimination of lymphatic filariasis in endemic countries - developing an action plan

AU - Kelly-Hope, Louise A

AU - Stanton, Michelle C

AU - Zouré, Honorat G M

AU - Kinvi, Boniface E

AU - Mikhailov, Alexei

AU - Tekle, Afework

AU - King, Jonathan D

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Background: Lymphatic filariasis (LF) is a vector-borne parasitic disease that is being targeted for elimination through mass drug administration (MDA). The co-distribution of Loa loa in Central Africa poses a significant barrier to the expansion of the MDA due to risk of severe adverse events (SAEs) associated with the drug ivermectin that is routinely used. National LF programmes are yet to significantly scale up in co-endemic areas and need a practical approach to make preliminary decisions based on the mapping status and potential treatment strategies.Methods: We reviewed relevant data available to WHO and in the literature for LF-L. loa endemic countries to develop a simple method to support the scale-up of MDA to eliminate LF.Results: A basic model for national LF programmes to work from at the administrative or implementation unit (IU) level has been developed for LF - L. loa co-endemic countries. The model includes five practical steps, which comprise the development of a national filarial database and a simple classification system to help determine the mapping status and most appropriate treatment strategy. Steps are colour-coded and linked to a general decision tree, which is also presented.Conclusions: This IU-level model is simple to follow and will help LF elimination programmes develop an action plan and scale up the implementation of alternative treatment strategies in L. loa co-endemic areas. The model could be further developed to incorporate the additional complexity of IUs where an intervention is required to eliminate onchocerciasis, particularly in hypo-endemic areas where ivermectin has not been used.

AB - Background: Lymphatic filariasis (LF) is a vector-borne parasitic disease that is being targeted for elimination through mass drug administration (MDA). The co-distribution of Loa loa in Central Africa poses a significant barrier to the expansion of the MDA due to risk of severe adverse events (SAEs) associated with the drug ivermectin that is routinely used. National LF programmes are yet to significantly scale up in co-endemic areas and need a practical approach to make preliminary decisions based on the mapping status and potential treatment strategies.Methods: We reviewed relevant data available to WHO and in the literature for LF-L. loa endemic countries to develop a simple method to support the scale-up of MDA to eliminate LF.Results: A basic model for national LF programmes to work from at the administrative or implementation unit (IU) level has been developed for LF - L. loa co-endemic countries. The model includes five practical steps, which comprise the development of a national filarial database and a simple classification system to help determine the mapping status and most appropriate treatment strategy. Steps are colour-coded and linked to a general decision tree, which is also presented.Conclusions: This IU-level model is simple to follow and will help LF elimination programmes develop an action plan and scale up the implementation of alternative treatment strategies in L. loa co-endemic areas. The model could be further developed to incorporate the additional complexity of IUs where an intervention is required to eliminate onchocerciasis, particularly in hypo-endemic areas where ivermectin has not been used.

U2 - 10.1186/s41256-017-0032-0

DO - 10.1186/s41256-017-0032-0

M3 - Journal article

C2 - 29202080

VL - 2

JO - Global health research and policy

JF - Global health research and policy

SN - 2397-0642

M1 - 12

ER -